USE OF IL-8 PROTEIN MODULATORS IN THE TREATMENT OF VIRAL INFECTIONS - Patent 1322319

(19)

(11)

EP 1 322 319 A1

(12)

(43)	Date of publication:
	02.07.2003 Bulletin 2003/27

(21)	Application number: 01975462.1

(22)	Date of filing: 25.09.2001

(51)	International Patent Classification (IPC)⁷: A61K 38/00, A61K 38/02, A61K 39/395

(86)	International application number:
	PCT/US0130/222

(87)	International publication number:
	WO 0202/4217 (28.03.2002 Gazette 2002/12)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

25.09.2000 US 234914 P

(71)	Applicant: SmithKline Beecham Corporation
	Philadelphia, PA 19103 (US)

(72)	Inventors:
	DILLON, Susan, B. Alamo, CA 94507 (US) TAL-SINGER, Ruth Collegeville, PA 19406 (US)

(74)	Representative: Giddings, Peter John, Dr. et al
	GlaxoSmithKlineCorporate Intellectual Property (CN9.25.1)980 Great West Road Brentford, Middlesex TW8 9GS Brentford, Middlesex TW8 9GS (GB)

(54)	USE OF IL-8 PROTEIN MODULATORS IN THE TREATMENT OF VIRAL INFECTIONS